Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
1,102.181,096.241,103.051,090.35
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
616.24616.24617.68609.10
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
1,189.721,194.741,202.791,188.58
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
1,725.691,730.021,762.991,730.02
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
643.62643.13643.17632.59
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
829.79832.32845.25832.32
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
213.40213.40216.07213.40
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
3,185.923,160.893,178.723,102.60
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
908.94912.57934.91912.57
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
1,478.961,478.171,482.911,466.65
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
2,405.362,390.342,402.532,359.18
ESPR:NASDAQ
Esperion Therapeutics Inc
$1.91
-3.05%
(-0.060) 1D
$1.94
+1.57% (+0.030)
After hours
Closed: Apr 23, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ESPR...
Open
$1.98
High
$2.00
Low
$1.90
Mkt. cap
491.64M
Avg. vol.
6.86M
Volume
20.00
52-wk high
$4.18
52-wk low
$0.69
EPS
-$0.11
Beta
1.17
Shares outstanding
256.81M
No. of employees
294
News stories
From sources across the web
Profile
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan. Wikipedia
About Esperion Therapeutics Inc
CEOSheldon Koenig
Employees294
FoundedMay 1998
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
65.00M
82.38M
87.31M
168.45M
Cost of goods sold
44.10M
35.78M
55.42M
41.78M
Cost of revenue
44.10M
35.78M
55.42M
41.78M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43.00M
39.51M
41.85M
41.43M
Operating expense
43.00M
39.51M
41.85M
41.43M
Total operating expenses
87.09M
75.29M
97.27M
83.21M
Operating income
-22.10M
7.10M
-9.96M
85.23M
Other non operating income
-28.00K
66.00K
-23.00K
-25.00K
EBT including unusual items
-40.46M
-12.72M
-31.33M
63.67M
EBT excluding unusual items
-40.46M
-12.72M
-31.33M
63.67M
Income tax expense
-
-
-
1.84M
Effective tax rate
-
-
-
2.89%
Other operating expenses
-
-
-
-
Net income
-40.46M
-12.72M
-31.33M
61.83M
Net profit margin
-62.24%
-15.45%
-35.89%
36.71%
Earnings per share
-0.21
-0.02
-0.16
0.22
Interest and investment income
1.10M
600.00K
700.00K
1.10M
Interest expense
-19.43M
-20.49M
-22.05M
-22.64M
Net interest expenses
-18.33M
-19.89M
-21.35M
-21.54M
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.07M
7.12M
-9.93M
85.26M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more